Clinical Trials Browser

NETWORK × Has results × Gynecologic × Clear all

Uterine Cervical Neoplasms

Squamous Intraepithelial Lesions, HIV Infections

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Squamous Intraepithelial Lesions, Acquired Immunodeficiency Syndrome, Anus Neoplasms, HIV Infections, Papillomavirus Infections

Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Ovarian Neoplasms, Stomach Neoplasms, Small Cell Lung Carcinoma

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

Fallopian Tube Neoplasms, Ovarian Neoplasms

Squamous Intraepithelial Lesions, Infections, Precancerous Conditions, Atypical Squamous Cells of the Cervix

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasm Metastasis, Ovarian Neoplasms, Pleural Effusion, Malignant

Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation

Uterine Cervical Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Granulosa cell tumor of the ovary, Ovarian gynandroblastoma, Sertoli-Leydig Cell Tumor

Vulvar Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Recurrent Uterine Corpus Carcinoma

Endometrial Clear Cell Adenocarcinoma

Brenner Tumor, Fallopian Tube Neoplasms

Carcinosarcoma, Fallopian Tube Neoplasms, Ovarian Neoplasms

Ovarian Germ Cell Cancer, Teratoma, Testicular Neoplasms, Endodermal Sinus Tumor

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Lymphedema, Vulvar Neoplasms

Squamous Intraepithelial Lesions

Uterine Cervical Neoplasms

Squamous Intraepithelial Lesions, Anus Neoplasms, Precancerous Conditions, HIV Infections, Papillomavirus Infections

Osteoporosis, Ovarian Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Brenner Tumor, Ovarian Neoplasms

Ovarian Neoplasms

Recurrent Uterine Corpus Carcinoma

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms, Endometrial Neoplasms

Brenner Tumor, Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Recurrent Uterine Corpus Sarcoma

Uterine Cervical Neoplasms

Uterine Cervical Neoplasms

Ovarian Germ Cell Cancer, Testicular Neoplasms, Carcinoma, Embryonal, Endodermal Sinus Tumor

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Brenner Tumor, Fallopian Tube Neoplasms, Nausea, Ovarian Neoplasms, Vomiting

Endometrial Adenocarcinoma

Sarcoma, Endometrial Stromal

Fallopian Tube Neoplasms, Ovarian Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

Uterine Cervical Neoplasms

Endometrial Adenocarcinoma

Endometrial Adenocarcinoma

Clinical Trials

Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy

Imiquimod, Fluorouracil, or Observation in Treating HIV-Positive Patients With High-Grade Anal Squamous Skin Lesions

Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery

SHAPE

ANCHOR

Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients

Vaccine Therapy in Preventing HPV in HIV-Positive Women in India

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Human Papillomavirus Vaccine Therapy in Treating Men With HIV-1 Infection

Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer

Bevacizumab With or Without Everolimus in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Paclitaxel and Carboplatin or Bleomycin Sulfate, Etoposide Phosphate, and Cisplatin in Treating Patients With Advanced or Recurrent Sex Cord-Ovarian Stromal Tumors

Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Cancer of the Vulva

Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer

Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer

Surgery and Combination Chemotherapy in Treating Children With Extracranial Germ Cell Tumors

Flexitouch® Home Maintenance Therapy or Standard Home Maintenance Therapy in Treating Patients With Lower-Extremity Lymphedema Caused by Treatment for Cervical Cancer, Vulvar Cancer, or Endometrial Cancer

Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia

Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer

Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia

Zoledronate or Observation in Maintaining Bone Mineral Density in Patients Who Are Undergoing Surgery to Remove Both Ovaries

Levonorgestrel in Preventing Ovarian Cancer in Patients at High Risk for Ovarian Cancer

Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer

Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Fulvestrant in Treating Patients With Recurrent, Persistent, or Metastatic Endometrial Cancer

Enzastaurin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer

Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer

Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery

A6 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer

Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer

ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer

Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix

Combination Chemotherapy in Treating Young Patients With Recurrent or Resistant Malignant Germ Cell Tumors

Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Mifepristone in Treating Patients With Recurrent or Persistent Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer

Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer

Dalantercept in Treating Patients With Recurrent or Persistent Endometrial Cancer

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

AMG 706 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer

Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer

Brivanib Alaninate in Treating Patients With Recurrent or Persistent Endometrial Cancer